Larimar Therapeutics
LRMR
#8139
Rank
ยฃ0.25 B
Marketcap
ยฃ2.40
Share price
-2.48%
Change (1 day)
-11.72%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): -ยฃ1.46

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.49. In 2025 the company made an earnings per share (EPS) of -ยฃ1.69 a decrease over its 2024 EPS that were of -ยฃ0.99.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.46-13.8%
2025-ยฃ1.6970%
2024-ยฃ0.99
2022-ยฃ1.18-48.15%
2021-ยฃ2.27-14.27%
2020-ยฃ2.65